XTLB
XTL Biopharmaceuticals Ltd ADR
NASDAQ: XTLB · HEALTHCARE · BIOTECHNOLOGY
$3.90
+9.55% today
Updated 2026-04-30
Market cap
$5.65M
P/E ratio
—
P/S ratio
5.84x
EPS (TTM)
$-3.60
Dividend yield
—
52W range
$2 – $10
Volume
2.3M
XTL Biopharmaceuticals Ltd ADR (XTLB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.15M | $26.90M | $14.13M | $3.43M | $715000.00 | $3.80M | $4.07M | $11.09M | $8.02M | $5.64M | $5.32M | $3.02M | $6.59M | $8.57M | $7.21M | $6.50M | $6.62M | $4.19M | $2.43M | $8.55M |
| Cash & equivalents | $13.36M | $4.40M | $2.38M | $2.92M | $412000.00 | $1.07M | $123000.00 | $1.70M | $2.89M | $2.16M | $3.82M | $2.02M | $3.29M | $3.25M | $4.46M | $3.63M | $2.97M | $2.09M | $1.40M | $371000.00 |
| Current assets | $13.79M | $26.10M | $13.90M | $3.39M | $557000.00 | $1.22M | $1.58M | $3.79M | $5.09M | $3.12M | $4.26M | $2.75M | $6.21M | $8.20M | $6.83M | $6.12M | $6.24M | $3.81M | $2.05M | $1.34M |
| Total liabilities | $3.90M | $4.14M | $5.56M | $2.00M | $708000.00 | $963000.00 | $629000.00 | $1.66M | $1.23M | $965000.00 | $436000.00 | $330000.00 | $2.97M | $253000.00 | $232000.00 | $254000.00 | $1.28M | $187000.00 | $206000.00 | $3.12M |
| Current liabilities | $2.41M | $3.40M | $5.37M | $2.00M | $708000.00 | $963000.00 | $629000.00 | $1.65M | $1.22M | $965000.00 | $436000.00 | $330000.00 | $300000.00 | $253000.00 | $232000.00 | $254000.00 | $231000.00 | $187000.00 | $206000.00 | $2.21M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $11.25M | $22.76M | $8.56M | $1.43M | $7000.00 | $2.83M | $3.44M | $7.35M | $6.26M | $4.66M | $4.89M | $2.69M | $3.62M | $8.32M | $6.98M | $3.61M | $5.33M | $4.00M | $2.22M | $5.43M |
| Retained earnings | $-99.79M | $-114.92M | $-139.86M | $-149.11M | $-141.22M | $-142.14M | $-143.28M | $-143.56M | $-146.07M | $-148.32M | $-152.49M | $-154.90M | $-155.65M | $-152.59M | $-153.93M | $-155.60M | $-155.13M | $-156.47M | $-158.25M | $-159.01M |
| Accounts receivable | $431000.00 | $444000.00 | $352000.00 | $354000.00 | $105000.00 | $110000.00 | $68000.00 | $126000.00 | $126000.00 | $13000.00 | $36000.00 | $12000.00 | $12000.00 | $22000.00 | — | — | $94000.00 | $71000.00 | $29000.00 | $99000.00 |
| Inventory | — | $287000.00 | $553000.00 | — | — | — | — | $229000.00 | $302000.00 | $892000.00 | $24000.00 | $130000.00 | $85000.00 | $-22000.00 | — | — | — | — | $-29000.00 | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $3.19M |